This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

14-16 September 2022
Westin Miyako KyotoKyoto, Japan

Toru Okamatsu
Acting General Manager of Business Development at Ajinomoto Bio-Pharma Services Osaka

Profile

Toru has worked for Ajinomoto Co., Inc. for 14 years. After gaining experience as Medicinal Chemist, Process Development of AJIPHASE® and CMC affairs, he has been responsible for Business Development and Project Management in Ajinomoto Bio-Pharma Services in Osaka for the past three years. From a CMC perspective, he is currently supporting customers’ oligonucleotide program with his team from pre-clinical to phase. Toru holds a M.S. in Kyushu University Graduate School of Science with organic chemistry.


Agenda Sessions

  • Oligonucleotide Manufacturing from Small to Large Scale

    10:00am